ILILHOW

Serial Number 98951653
653

Registration Progress

Application Filed
Jan 10, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

ILILHOW

Basic Information

Serial Number
98951653
Filing Date
January 10, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
653
Status Date
Jan 15, 2026
Application
Pending
Classes
005 029

Rights Holder

Samil Pharmaceutical Co., Ltd.

16
Address
155 Hyoryeong-Ro
Seocho-Gu, Seoul 06666
KR

Ownership History

Samil Pharmaceutical Co., Ltd.

Original Applicant
16
Seocho-Gu, Seoul KR

Legal Representation

Attorney
Mark Hendricksen

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jan 15, 2026 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jan 15, 2026 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Jan 15, 2026 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jan 12, 2026 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 12, 2026 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 12, 2026 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Dec 1, 2025 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Dec 1, 2025 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Aug 29, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 29, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 23, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 22, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 10, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; nutraceuticals for use as dietary supplements; ophthalmic preparations; allergy medications; chemico-pharmaceutical preparations, namely, pharmaceutical preparations for treating chemical imbalances; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; medicines for dental purposes; therapeutic drugs and agents being pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations for the treatment of respiratory diseases adn disorders found in respiratory organs;
Class 029
prepared meat; health food supplements primarily based on processed Chinese matrimony vine; processed fish; processed cheese; pumpkin juice for culinary purposes; preserved, frozen, dried and cooked fruits and vegetables; health food supplement based on dried fish and shellfish; health food supplement primarily based on deer antlers; processed beans; fish; processed algae for human consumption; oils for food; meat, fish, poultry and game, not live; milk products excluding ice cream, ice milk and frozen yogurt; health food supplement primarily based on seaweed;

Classification

International Classes
005 029